肥胖的2型糖尿病中国患者行Roux-en-Y胃旁路术后糖尿病肾病的短期缓解情况
The Short-Term Remission of Diabetic Nephropathy After Roux-en-Y Gastric Bypass in Chinese Patients of T2DM with Obesity.
作者信息
Zhang Hongwei, Di Jianzhong, Yu Haoyong, Han Xiaodong, Li Kun, Zhang Pin
机构信息
Department of General Surgery, The Sixth People's Hospital Affiliated to Shanghai Jiao Tong University, Shanghai, 200233, China.
出版信息
Obes Surg. 2015 Jul;25(7):1263-70. doi: 10.1007/s11695-015-1666-y.
Abstract
The study aimed to examine the effect of gastric bypass on diabetic nephropathy (DN) in Chinese patients. A retrospective study of 101 samples with DN stages I to IV underwent Roux-en-Y gastric bypass. Anthropometric and biochemical parameters were assessed during a 1-year follow-up. Binary logistic regression analysis was used for predictors and ROC for cutoff points. There was significant reduction of medication for diabetes and hypertension. Overall remission of T2DM was 80.2 %. Preoperative albumin/creatinine ratio (ACR) and serum creatinine (SCr) levels could be predictors for DN remission, and the cutoff points were 126 mg/g cr and 57 μmol/L, respectively. Gastric bypass showed improvement of T2DM and DN. Gastric bypass may be more beneficial for those with lower preoperative ACR and SCr.
摘要
该研究旨在探讨胃旁路手术对中国糖尿病肾病（DN）患者的影响。对101例I至IV期DN患者进行了回顾性研究，这些患者接受了Roux-en-Y胃旁路手术。在1年的随访期间评估了人体测量和生化参数。采用二元逻辑回归分析预测因素，采用ROC分析确定切点。糖尿病和高血压药物用量显著减少。2型糖尿病的总体缓解率为80.2%。术前白蛋白/肌酐比值（ACR）和血清肌酐（SCr）水平可作为DN缓解的预测指标，切点分别为126 mg/g cr和57 μmol/L。胃旁路手术改善了2型糖尿病和DN。胃旁路手术可能对术前ACR和SCr较低的患者更有益。
相似文献
1
The Short-Term Remission of Diabetic Nephropathy After Roux-en-Y Gastric Bypass in Chinese Patients of T2DM with Obesity.
Obes Surg. 2015 Jul;25(7):1263-70. doi: 10.1007/s11695-015-1666-y.
2
Effect of Roux-en-Y Gastric Bypass on Remission of T2D: Medium-Term Follow-up in Chinese Patients with Different BMI Obesity Class.
Obes Surg. 2017 Jan;27(1):134-142. doi: 10.1007/s11695-016-2262-5.
3
Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects.
Ann Surg. 2012 Dec;256(6):1023-9. doi: 10.1097/SLA.0b013e318262ee6b.
4
Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass.
Surg Obes Relat Dis. 2010 May-Jun;6(3):254-9. doi: 10.1016/j.soard.2009.11.003. Epub 2009 Nov 10.
5
The Predictive Factors for Diabetic Remission in Chinese Patients with BMI > 30 kg/m and BMI < 30 kg/m Are Different.
Obes Surg. 2018 Jul;28(7):1943-1949. doi: 10.1007/s11695-017-3106-7.
6
Effects of Laparoscopic Roux-en-Y Gastric Bypass on Chinese Type 2 Diabetes Mellitus Patients with Different Levels of Obesity: Outcomes After 3 Years' Follow-Up.
Obes Surg. 2018 Mar;28(3):702-711. doi: 10.1007/s11695-017-2903-3.
7
Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss.
Surg Obes Relat Dis. 2009 May-Jun;5(3):305-9. doi: 10.1016/j.soard.2009.02.007. Epub 2009 Feb 26.
8
Remission of Type 2 Diabetes Mellitus (T2DM) after Sleeve Gastrectomy (SG), One-Anastomosis Gastric Bypass (OAGB), and Roux-en-Y Gastric Bypass (RYGB): A Systematic Review.
Medicina (Kaunas). 2023 May 19;59(5):985. doi: 10.3390/medicina59050985.
9
Prediction of Diabetes Remission in Morbidly Obese Patients After Roux-en-Y Gastric Bypass.
Obes Surg. 2016 Apr;26(4):749-56. doi: 10.1007/s11695-015-1823-3.
10
Weight loss independently predicts urinary albumin excretion normalization in morbidly obese type 2 diabetic patients undergoing bariatric surgery.
Surg Endosc. 2013 Jun;27(6):2046-51. doi: 10.1007/s00464-012-2708-3. Epub 2013 Jan 5.
引用本文的文献
1
The Impact of Metabolic and Bariatric Surgery on Diabetic Kidney Disease in Patients with Type 2 Diabetes: A Systematic Review and Meta-analysis.
Obes Surg. 2025 Jan;35(1):329-340. doi: 10.1007/s11695-024-07612-8. Epub 2024 Dec 10.
2
Improvement of Renal Function After Bariatric Surgery: a Systematic Review and Meta-analysis.
Obes Surg. 2021 Oct;31(10):4470-4484. doi: 10.1007/s11695-021-05630-4. Epub 2021 Aug 6.
3
Metabolic surgery in China: present and future.
J Mol Cell Biol. 2021 Jul 7;13(8):594-609. doi: 10.1093/jmcb/mjab039.
4
Timing of Maximal Weight Reduction Following Bariatric Surgery: A Study in Chinese Patients.
Front Endocrinol (Lausanne). 2020 Sep 15;11:615. doi: 10.3389/fendo.2020.00615. eCollection 2020.
5
Is Roux-en-Y gastric bypass advantageous?-surgical outcomes in obese patients with type-2 diabetes after gastric bypass versus sleeve gastrectomy, a matched retrospective study.
Ann Transl Med. 2020 Mar;8(6):372. doi: 10.21037/atm.2020.02.08.
6
Uric acid level changes after bariatric surgery in obese subjects with type 2 diabetes mellitus.
Ann Transl Med. 2019 Jul;7(14):332. doi: 10.21037/atm.2019.06.66.
7
Long-term impact of bariatric surgery in diabetic nephropathy.
Surg Endosc. 2019 May;33(5):1654-1660. doi: 10.1007/s00464-018-6458-8. Epub 2018 Sep 24.
8
The ZDSD rat: a novel model of diabetic nephropathy.
Am J Transl Res. 2017 Sep 15;9(9):4236-4249. eCollection 2017.
9
Effects of Bariatric Surgery on Renal Function in Obese Patients: A Systematic Review and Meta Analysis.
PLoS One. 2016 Oct 4;11(10):e0163907. doi: 10.1371/journal.pone.0163907. eCollection 2016.
本文引用的文献
1
Visceral fat area as a new predictor of short-term diabetes remission after Roux-en-Y gastric bypass surgery in Chinese patients with a body mass index less than 35 kg/m2.
Surg Obes Relat Dis. 2015 Jan-Feb;11(1):6-11. doi: 10.1016/j.soard.2014.06.019. Epub 2014 Jul 14.
2
Therapeutic strategies of diabetic nephropathy: recent progress and future perspectives.
Drug Discov Today. 2015 Mar;20(3):332-46. doi: 10.1016/j.drudis.2014.10.007. Epub 2014 Oct 31.
3
Effect of Laparoscopic Roux-en-Y Gastric Bypass Surgery on Obstructive Sleep Apnea in a Chinese Population with Obesity and T2DM.
Obes Surg. 2015 Aug;25(8):1446-53. doi: 10.1007/s11695-014-1510-9.
4
Significant improvement of erectile function after Roux-en-Y gastric bypass surgery in obese Chinese men with erectile dysfunction.
Obes Surg. 2015 May;25(5):838-44. doi: 10.1007/s11695-014-1465-x.
5
Diabetic nephropathy - complications and treatment.
Int J Nephrol Renovasc Dis. 2014 Oct 15;7:361-81. doi: 10.2147/IJNRD.S40172. eCollection 2014.
6
Endogenous fructose production and fructokinase activation mediate renal injury in diabetic nephropathy.
J Am Soc Nephrol. 2014 Nov;25(11):2526-38. doi: 10.1681/ASN.2013080901. Epub 2014 May 29.
7
Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.
N Engl J Med. 2014 May 22;370(21):2002-13. doi: 10.1056/NEJMoa1401329. Epub 2014 Mar 31.
8
Genetic associations in diabetic nephropathy.
Clin Exp Nephrol. 2014 Apr;18(2):197-200. doi: 10.1007/s10157-013-0874-9. Epub 2013 Oct 16.
9
Prevalence and control of diabetes in Chinese adults.
JAMA. 2013 Sep 4;310(9):948-59. doi: 10.1001/jama.2013.168118.
10
Bariatric surgery versus conventional medical therapy for type 2 diabetes.
N Engl J Med. 2012 Apr 26;366(17):1577-85. doi: 10.1056/NEJMoa1200111. Epub 2012 Mar 26.
Zotero 插件